Confusion and Constipation in Metastatic Breast Cancer
Mrs. L is 59 with hormone receptor-positive, HER2-negative metastatic breast cancer involving the ribs, spine, and pelvis. She takes letrozole, palbociclib, denosumab every four weeks, and calcium plus vitamin D. Over five days she has developed worsening confusion, constipation, nausea, thirst, and two episodes of emesis. Her family attributes it to being 'tired from treatment.' Vital signs: heart rate 104, blood pressure 96/58 supine, afebrile. Mucous membranes are dry and she is drowsy but arousable. Labs: calcium 14.2 mg/dL, albumin 3.2 g/dL, creatinine 1.7 mg/dL (baseline 0.8), potassium 3.1 mEq/L.
1. What is your interpretation of this presentation, and what are the immediate priorities?
Read the worked answer
This is hypercalcemia of malignancy with volume depletion and acute kidney injury, and it is an emergency. The corrected calcium is even higher than the reported value given her low albumin. Attributing the confusion to treatment fatigue is exactly the error to avoid; new confusion in a patient with bone metastases should prompt a calcium and creatinine check immediately.
Other contributors to consider and address: thiazide diuretics, recent immobilization, over-replacement of calcium and vitamin D, dehydration, and, less commonly, ectopic production from a second malignancy. Review her medication list before assuming a single cause.
Immediate priorities are restoring intravascular volume with intravenous 0.9% sodium chloride, typically 200 to 500 mL per hour titrated to urine output and cardiac and renal status, holding calcium and vitamin D supplements, and arranging urgent evaluation rather than outpatient management. She is symptomatic and hypotensive, so she needs a monitored setting. Also assess for constipation as a contributor to nausea and for any fall risk with her confusion and bone lesions.
2. What pharmacologic therapy for the hypercalcemia is appropriate given her renal function, and what monitoring is required?
Read the worked answer
Antiresorptive therapy plus volume resuscitation, layered by speed of onset. Calcitonin 4 IU/kg subcutaneously every 12 hours lowers calcium within hours but tachyphylaxis develops in about 48 hours, so it is a bridge, not a plan.
For definitive therapy, check a calculated creatinine clearance. Zoledronic acid requires a CrCl of at least 30 mL/min, and her creatinine of 1.7 puts her near or below that threshold depending on weight, so calculate rather than guess. If clearance is adequate, zoledronic acid 4 mg intravenously with appropriate dose reduction for renal function is appropriate. If clearance is below 30 mL/min, denosumab 120 mg subcutaneously is the preferred agent because it is not renally cleared. Loop diuretics are not routine and are used only if she becomes volume overloaded after saline.
Monitor calcium, magnesium, phosphorus, and creatinine at least daily. After an antiresorptive takes effect, watch for symptomatic hypocalcemia, particularly with denosumab and with vitamin D deficiency. Hold her scheduled denosumab until the acute episode is controlled and calcium is stable.
3. What supportive and coordination steps belong in the plan, and what would you teach the family?
Read the worked answer
Treat the constipation actively with a scheduled bowel regimen, since opioids and hypercalcemia both cause it and it will recur. Give scheduled antiemetics rather than as-needed only. Mobilize her as safely as possible given bone lesions, with fall precautions.
Teach the family the red flags that mean call now rather than at the next appointment: new confusion, drowsiness, vomiting that prevents oral intake, decreased urination, thirst, or weakness. Explain that hypercalcemia recurs and that calcium and creatinine will be checked with labs going forward, especially after any change in antiresorptive therapy.
Coordinate with oncology to review the planned regimen, with nephrology if renal function does not recover, and with palliative care for symptom burden and goals-of-care discussions, which should not wait for a crisis. Confirm who is responsible for follow-up labs and who the family should call after hours. Reassess her understanding, since part of the danger here was the family's reasonable but incorrect assumption that this was just treatment fatigue.